These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 510999)

  • 21. A current review of the clinical experience with Estracyt.
    Murphy GP
    Prog Clin Biol Res; 1987; 243B():221-5. PubMed ID: 3309982
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution to the mechanism of Stilbostat action.
    Görlich M; Heise E
    Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).
    Hartley-Asp B; Gunnarsson PO
    J Urol; 1982 Apr; 127(4):818-22. PubMed ID: 7069864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estracyt--mode of action and clinical experience.
    Hedlund PO
    Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fundamental investigation of estradiol-3N-bis-(2-chloroethyl) carbamate-17 beta-phosphate (Estracyt)-on the antiprostatic effect of this drug (author's transl)].
    Yamanaka H; Koya J; Imai K; Nakai K; Yuasa H
    Horumon To Rinsho; 1981 Apr; 29(4):477-85. PubMed ID: 7296919
    [No Abstract]   [Full Text] [Related]  

  • 28. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estramustine--current status, 1983.
    Ahlgren JD
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):46-7. PubMed ID: 6364367
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug information. Estramustini phophas (Estracyt)].
    Helsingborg/Lundbeck L
    Ugeskr Laeger; 1975 Sep; 137(38):2203-4. PubMed ID: 1166562
    [No Abstract]   [Full Text] [Related]  

  • 31. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
    Buchanan LJ; Riches AC
    Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estramustine and its constituents on human malignant glioma cells.
    von Schoultz E; Lundgren E; Henriksson R
    Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estramustine binding site in human breast cancer biopsy samples. Its relation to estrogen and progesterone receptor levels, age and menopausal status.
    Fernö M; Borg A; Idvall I
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1505-10. PubMed ID: 3678314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 35. The synthesis of 3H labelled steroid-nitrogen mustard derivatives and studies on their action in rat and human prostate.
    Symes EK; Milroy EJ
    J Steroid Biochem; 1982 Jul; 17(1):23-30. PubMed ID: 7109589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):188-98. PubMed ID: 1173982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine receptor-estradiol complexes and their interaction with nuclear binding sites.
    Clark JH; Eriksson HA; Hardin JW
    J Steroid Biochem; 1976; 7(11-12):1039-43. PubMed ID: 1025347
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve.
    Kanje M; Deinum J; Wallin M; Ekström P; Edström A; Hartley-Asp B
    Cancer Res; 1985 May; 45(5):2234-9. PubMed ID: 2580617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
    Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
    Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of oral estramustine phosphate (Estracyt) in prostatic carcinoma: influences on lipid and carbohydrate metabolism.
    Gustafson A; Persson B; Tisell LE; Wiklund O; Ohlson R
    Invest Urol; 1977 Nov; 15(3):220-4. PubMed ID: 591268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.